← Open Payments lookup

ROBERT NEBORSKY: Open Payments

NPI 1871610345 · DEL MAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$661 in 22 payments from 9 companies in 2025. Trend: 2023 $1,447 · 2024 $1,071 · 2025 $661

Food & beverage: $661
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$194
Alkermes, Inc.1$119
Takeda Pharmaceuticals U.S.A., Inc.5$109
Lundbeck LLC3$68
Janssen Pharmaceuticals, Inc3$62
ABBVIE INC.2$33
Axsome Therapeutics, Inc.1$29
Vanda Pharmaceuticals Inc.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: REXULTI, LYBALVI, TRINTELLIX, SPRAVATO, VRAYLAR, Auvelity, FANAPT, CAPLYTA.

Industry payments across CA — which companies pay providers there.